Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ
A review of sarilumab for the treatment of rheumatoid arthritis | Immunotherapy
Actemra Shortage: What to Do If You Can't Access Tocilizumab
Frontiers | Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 | Pharmacology
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia | SpringerLink
JCI - IL-6 polymorphisms: a useful genetic tool for inflammation research?
Tocilizumab-Atlizumab Overview - Creative Biolabs
Frontiers | Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis | Pharmacology
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis - ScienceDirect
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
![The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10322/1/fig-3-full.png "The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]")
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]
Mechanism of action of tocilizumab in RA (bathtub theory). Notes: The... | Download Scientific Diagram
Immunomodulation as a potent COVID-19 pharmacotherapy | JIR
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis | Therapeutic Delivery
How is Actemra® (tocilizumab) for GCA believed to work?
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis | Infectious Diseases of Poverty | Full Text
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19 - ScienceDirect
Interleukin-6 inhibition in the management of non-infectious uveitis and beyond | Journal of Ophthalmic Inflammation and Infection | Full Text
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
